1. US Food and Drug Administration. CFR Code of Federal Regulations, Title 21: Current Good Manufacturing Practice for Finished Pharmaceuticals, Part 211 (2017).
2. U. R. Mallu, A. K. Nair, S. Bandaru, and J. Sankaraiah, Review. Pharm Reg. Aff., 1(4), 1 – 8 (2012).
3. The British Pharmacopoeia, British Pharmacopoeia Commission Stationery Office: London (2021).
4. G. R. Brown, Clin. Pharmacokinet., 24(4), 289 – 300 (1993).
5. B. Nair, Int. J. Toxicol., 20, 23 – 50 (2001).